Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes

Endocrine Practice

Volumn 10, Issue 2, 2004, Pages 101-106

  Litonjua, Patrick ^a   Piñero Piloña, Antonio ^a   Aviles Santa, Larissa ^a   Raskin, Philip ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ACANTHOSIS NIGRICANS; ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; DIABETES MELLITUS; DOSE RESPONSE; ETHNOLOGY; FEMALE; HISPANIC; HUMAN; MALE; MEDICAL RECORD; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; STATISTICS;

ACANTHOSIS NIGRICANS; ADULT; AFRICAN AMERICANS; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HISPANIC AMERICANS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEDICAL RECORDS; MIDDLE AGED; OBESITY; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 4344716720     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.10.2.101     Document Type: Article

References (23)

1. Matsuoka LY, Wortsman JM, Gavin JR, Goldman JP. Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med. 1987;83:719-725.
2. Winkelmann RK, Scheen SR, Underdahl LO. Acanthosis nigricans and endocrine disease. JAMA. 1960;174:1145-1152.
3. Matsuoka LY, Wortsman J, Gavin JR, Kupchella CE, Dietrich JG. Acanthosis nigricans, hypothyroidism and insulin resistance. Am J Med. 1986;81:58-62.
4. Flier JS. Metabolic importance of acanthosis nigricans. Arch Dermatol. 1985;121:193-194.
5. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 1987;65:499-507̀.
6. Stuart CA, Gilkison CR, Smith MM, et al. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr. 1998;37:73-79.
7. Taylor SI, Accili D, Imiai Y. Insulin resistance or insulin defi ciency: which is the primary cause of NIDDM? Diabetes. 1994;43:735-740.
8. The Expert Committee on the Diagnosis and Classifi cation of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classifi cation of Diabetes Mellitus. Diabetes Care. 1997;20:1-15.
9. Kahn RC, Flier JS, Bar RS, et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 1976;294:739-745.
10. Stone OJ. Acanthosis nigricans-decreased extracellular matrix viscosity: cancer, obesity, diabetes, corticosteroids, somatrophin. Medical Hypotheses. 1993;40:154-157.
11. Pugeat M, Ducluzeau PH, Mallion-Donadieu M. Association of insulin resistance with hyperandrogenia in women. Horm Res. 2000;54:322-326.
12. Taylor SI, Accili D, Imiai Y. Insulin resistance or insulin defi ciency: which is the primary cause of NIDDM? Diabetes. 1994;43:735-740.
13. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 1989;87: 269-272.
14. Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM. Acanthosis nigricans among native americans: an indicator of high diabetes risk. Am J Public Health. 1994;84:1839-1842.
15. Hud JA, Cohen JB, Wagner JM, Cruz PD. Prevalence and signifi cance of acanthosis nigricans in an adult obese population. Arch Derm. 1992;128:941-944.
16. Flier JS, Eastman RC, Minaker KL, Matteson D, Rowe JW. Acanthosis nigricans in obese women with hyperandrogenism: characterization of an insulin-resistant state distinct from type A and B syndromes. Diabetes. 1985;34:101-107.
17. Stuart CA, Driscoll MS, Lundquist KF, Gilkison CR, Shaheb S, Smith MM. Acanthosis nigricans. J Basic Clin Physiol Pharmacol. 1998;9:407-418.
18. Bent KN, Shuster GF, Hurley JS, Frye D, Lofl in P, Brubaker C. Acanthosis nigricans as an early clinical proxy marker of increased risk of type II diabetes. Public Health Nurs. 1998;15:415-421.
19. Olefsky JM. Obesity. In Wilson JD, Brauwald E, Isselbacker KJ, et al, eds. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill International Book Co. 1991:413-414.
20. Unger RH, Grundy S. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia. 1985;28:119-121.
21. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
22. Goldstein BJ. Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol. 2002;90:3G-10G.
23. Greenburg AS, McDaniel ML. Identifying the links between obesity, insulin resistance, and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest. 2002;32: 24-34.